Adjunctive usage of a non-comedogenic moisturizer with adapalene gel 0.1% improves local tolerance: a randomized, investigator-blinded, split-face study in healthy Asian subjects

References

• Taylor SC, Cook-Bolden F, Rahman Z, Strachan D. Acne vulgaris in skin of color. J Am Acad Dermatol. 2002;46:S98–S106.
   Google Scholar
• Perkins AC, Cheng CE, Hillebrand GG, Miyamoto K, Kimball AB. Comparison of the epidemiology of acne vulgaris among Caucasian, Asian, Continental Indian and African American women. J Eur Acad Dermatol Venereol. 2010;25:1054–1060.
   PubMedGoogle Scholar
• Tan HH, Tan AW, Barkham T, Yan XY, Zhu M. Community-based study of acne vulgaris in adolescents in Singapore. Br J Dermatol. 2007;157:547–551.
   PubMed Web of Science ®Google Scholar
• Kubota Y, Shirahige Y, Nakai K, Katsuura J, Moriue T, Yoneda K. Community-based epidemiological study of psicosocial effects of acne in Japanese adolescents. J Dermatol. 2010;37:617–622.
   PubMedGoogle Scholar
• Hayashi N, Higaki Y, Kawamoto K, Kamo T, Shimizu S, Kawashima M. A cross-sectional analysis of quality of life in Japanese acne patients using the Japanese version of Skindex-16. J Dermatol. 2004;31:971–976.
   PubMedGoogle Scholar
• Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ, et al. Management of acne. A report from a Global Alliance to Improve Outcomes in Acne. J AM Acad Dermatol. 2003;49(1 Suppl):S1–S37.
   Web of Science ®Google Scholar
• Hayashi N, Akamatsu H, Iwatsuki K, Kurokawa I, Kono T, Tanioka M, et al. Guidelines for management of acne vulgaris. Jpn J Dermatol. 2008;118:1893–1923.
   Google Scholar
• Shalita A, Weiss JS, Chalker DK, Ellis CN, Greenspan A, Katz HI, et al. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acny vulgaris: a multicenter trial. J Am Acad Dermatol. 1996;34:482–485.
   PubMed Web of Science ®Google Scholar
• Cunliffe WJ, Caputo R, Dreno B, Förström L, Heenen M, Orfanos CE, et al. Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris: Europe and U.S multicenter trials. J Am Acad Dermatol. 1997;36:S126–S134.
   Web of Science ®Google Scholar
• Kawashima M, Harada S, Czernielewski J, Miyachi Y. Adapalene gel 0.1% -topical retinoidlike molecule for the treatment of Japanese patients with acne vulgaris: a multicenter randomized, investigator-blinded, doses-ranging study. Skin Res. 2007;6:494–503.
   Google Scholar
• Kawashima M, Harada S, Andres P, Miyachi Y. One-Year efficacy and safety of adapalene gel 0.1% in Japanese patients with acne vulgaris. Skin Res. 2007;6:504–512.
   Google Scholar
• Kawashima M, Harada S, Loesche C, Miyachi Y. Adapalene gel 0.1% is effective and safe for Japanese patients with acne vulgaris: a randomized, multicenter investigator-blinded, controlled study. J Dermatol Sci. 2008;49:241–248.
   PubMed Web of Science ®Google Scholar
• Cunliffe WJ, Poncet M, Loesche C, Verschoore M. A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: a meta-analysis of five randomized trials. Br J Dermatol. 1998;139:48–56.
   PubMed Web of Science ®Google Scholar
• Greenspan A, Loesche C, Vendetti N, Georgeian K, Gibert R, Poncet M, et al. Cumulative irritation comparison of adapalene gel and solution with 2 tazarotene gels and 3 tretinoin formulations. Cutis. 2003;72:76–81.
   PubMed Web of Science ®Google Scholar
• Brand B, Gilbert R, Baker MD, Poncet M, Greenspan A, Georgeian K, et al. Cumulative irritancy comparison of adapalene gel 0.1% versus other retinoid products when applied in combination with topical antimicrobial agents. J Am Acad Dermatol. 2003;49(3 Suppl):S227–S232.
   PubMed Web of Science ®Google Scholar
• Dunlap FE, Mills OH, Tuley MR, Baker MD, Plott RT. Adapalene 0.1% gel for the treatment of acne vulgaris: its superiority compared to tretinoin 0.025% cream in skin tolerance and patient preference. Br J Dermatol. 1998;139:17–22.
   PubMed Web of Science ®Google Scholar
• Caron D, Sorba V, Kerrouche N, Clucas A. Split-face comparison of adapalene 0.1% gel and tretinoin 0.025% gel in acne patients. J Am Acad Dermatol. 1997;36:S110–S112.
   PubMed Web of Science ®Google Scholar
• Egan N, Loesche MC, Baker MM. Randomized, controlled, bilateral (split-face) comparison trial of the tolerability and patient preference of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris. Cutis. 2001;68(Suppl 4):20–24.
   PubMedGoogle Scholar
• Zhu X-J, Tu P, Zhen J, Duan YQ. Adapalene Gel 0.1%: effective and well tolerated in the topical treatment of acne vulgaris in Chinese patients. Cutis. 2001;68:55–59.
   PubMedGoogle Scholar
• Tu P, Li G-Q, Zhu X-J, Zhen J, Wong W-Z. A comparison of adapalene gel 0.1% vs tretinoin gel 0.025% in the treatment of acne vulgaris in China. J Eur Acad Dermatol Venereol. 2001;15(Suppl 3):31–36.
   PubMed Web of Science ®Google Scholar
• Goh CL, Tang MB, Briantais P, Kaoukhov A, Soto P. Adapalene gel 0.1% is better tolerated than tretinoin gel 0.025% among healthy volunteers of various ethnic origins. J Dermatolog Treat. 2009;20:282–288.
   PubMed Web of Science ®Google Scholar
• Laquieze S, Czernielewski J, Rueda MJ. Beneficial effect of a moisturizing cream as adjunctive treatment to oral isotretinoin or topical tretinoin in the management of acne. J Drugs Dermatol. 2006;5:985–990.
   PubMedGoogle Scholar
• Kubota Y, Munehiro A, Shirahige Y, Nakai K, Katsuura J, Moriue T, et al. Effect of sequential application of topical adapalene and clindamicin phosphate in the treatment of Japanese patients with acne vulgaris. J Dermatolog Treat. 2012;23:37–45.
   PubMed Web of Science ®Google Scholar
• Katsambas AD. Why and when the treatment of acne fails. What to do. Dermatology. 1998;196:158–161.
   PubMed Web of Science ®Google Scholar